<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Resting Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells (Daudi) in culture are more sensitive targets for the antiproliferative activity of purified human fibroblast interferon than cells that are rapidly multiplying </plain></SENT>
<SENT sid="1" pm="."><plain>Thus, interferon may be of significant clinical value in <z:hpo ids='HP_0002664'>neoplasms</z:hpo> involving stem cells and, after chemotherapy, in suppressing the reemergence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>